Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Patient advocacy groups are often funded through pharmaceutical companies, but there are currently no regulations governing ...

The FDA is to review Sanofi/Regeneron's Dupixent as a treatment ... the latest in a new wave of injected therapies, along with GlaxoSmithKline’s Nucala and Teva’s Cinqaero.

Patient groups should be playing a central role in Canada's health-care system, advocating for their members by promoting the ...

Archana Chatterjee has received research grants from Merck, GlaxoSmithKline, Sanofi Pasteur, Novartis, Wyeth and MedImmune. She has also served on the Speakers Bureau for Merck, GlaxoSmithKline ...

Sanofi is one of the largest pharmaceutical ... which it later sold to GlaxoSmithKline who marketed the drug as Thorazine. In 1990, it merged with another company to form Rhône-Poulenc Rorer.

Teva Pharmaceutical Industries Ltd. ADR-0.76% $19.75B ...

Nigeria’s health sector has come under pressure following the exit of foreign pharmaceutical companies, a void that has led ...

New York, USA, Oct. 03, 2024 (GLOBE NEWSWIRE) — Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight The increasing incidence of respiratory conditions ...

The encouraging news is that Nigeria is set to take a significant step towards economic independence and energy security on ...